Breaking News Instant updates and real-time market news.

2020-05-04 06:13:40 FLR Fluor $10.20 / -1.53 (-13.04%) 06:13 05/04/20 05/04 06:13 05/04/20 06:13	Fluor provides update on review of two projects Fluor provided updates on the two projects that were subject to developments contributing to the delay of Fluor's Form 10-K filing. Fluor, along with its joint venture partners on the Purple Line Rail Project in Maryland, informed the lead contracting and finance consortium for the project of the joint venture's intent to terminate the design-build contract. There were multiple delays on the project and the joint venture was unable to obtain the time and cost relief to which it is entitled from the Maryland Department of Transportation and Maryland Transportation Authority. This decision avoids the joint venture having to fund significant future delay and impact costs associated with completing the project. The joint venture will work with MDOT and the MTA to ensure an orderly transition. This process is expected to take approximately 60 to 90 days and is reimbursable under the contract. As a result of this termination, Fluor's project backlog will be reduced by approximately $1.2B. The company does not anticipate any material adjustments.
FLR Fluor $10.20 / -1.53 (-13.04%) 04/27/20 Citi Fluor downgraded to Neutral from Buy at Citi 04/27/20 UBS Fluor downgraded to Neutral from Buy at UBS 02/19/20 Fly Intel: Top five analyst downgrades 02/19/20 DA Davidson Fluor price target lowered to $15 from $22 at DA Davidson

2020-05-04 06:13:40

FLR

Fluor

$10.20 / -1.53 (-13.04%)

06:13

05/04/20

05/04

06:13

05/04/20

06:13

Fluor provides update on review of two projects

Fluor provided updates on the two projects that were subject to developments contributing to the delay of Fluor's Form 10-K filing. Fluor, along with its joint venture partners on the Purple Line Rail Project in Maryland, informed the lead contracting and finance consortium for the project of the joint venture's intent to terminate the design-build contract. There were multiple delays on the project and the joint venture was unable to obtain the time and cost relief to which it is entitled from the Maryland Department of Transportation and Maryland Transportation Authority. This decision avoids the joint venture having to fund significant future delay and impact costs associated with completing the project. The joint venture will work with MDOT and the MTA to ensure an orderly transition. This process is expected to take approximately 60 to 90 days and is reimbursable under the contract. As a result of this termination, Fluor's project backlog will be reduced by approximately $1.2B. The company does not anticipate any material adjustments.

FLR Fluor

$10.20 / -1.53 (-13.04%)

04/27/20 Citi: Fluor downgraded to Neutral from Buy at Citi

04/27/20 UBS: Fluor downgraded to Neutral from Buy at UBS

02/19/20: Fly Intel: Top five analyst downgrades

02/19/20 DA Davidson: Fluor price target lowered to $15 from $22 at DA Davidson

TODAY'S FREE FLY STORIES

Hot Stocks	Novocure: DMC recommends continuation of LUNAR trial » 07:40 04/13/21 04/13 07:40 04/13/21 07:40 NVCR Novocure $131.91 / -0.1 (-0.08%) , ZLAB Zai Lab $132.00 / -0.84 (-0.63%) Zai Lab Limited (ZLAB)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events NVCR ZLAB NVCR Novocure $131.91 / -0.1 (-0.08%) 12/14/20 Novocure announces BAG to add Optune combination to MiGeL 12/10/20 Novocure enrolls 1st patient in global phase 3 TRIDENT trial 11/11/20 Novocure receives CE Mark for NovoTTF-100L system 10/29/20 Novocure forms alliance with NYU Grossman School of Medicine ZLAB Zai Lab $132.00 / -0.84 (-0.63%) 03/31/21 Zai Lab, Deciphera announce China NMPA approval of Qinlock NDA 01/11/21 Turning Point Therapeutics, Zai Lab expand collaboration to include TPX-0022 01/08/21 Argenx expects 2021 cash burn 'approximately doubling' compared to 2020 01/08/21 Argenx announces submission of BLA to FDA for efgartigimod in gMG treatment NVCR ZLAB NVCR Novocure $131.91 / -0.1 (-0.08%) 03/01/21 Mizuho Novocure price target raised to $175 from $150 at Mizuho 02/25/21 Piper Sandler 'Overreaction to downside' in Novocure a buying opportunity, says Piper Sandler 01/29/21 Truist Novocure price target raised to $132 from $118 at Truist 01/25/21 Piper Sandler Novocure price target raised to $225 from $140 at Piper Sandler ZLAB Zai Lab $132.00 / -0.84 (-0.63%) 02/08/21 Jefferies Zai Lab price target raised to $225 upon assumption at Jefferies 01/15/21 Citi Citi boosts Zai Lab target to $216, adds to U.S. Focus List 01/07/21 Wedbush Argenx price target raised to $293 from $283 at Wedbush 11/16/20 JPMorgan Zai Lab price target raised to $111 from $101 at JPMorgan NVCR ZLAB NVCR Novocure $131.91 / -0.1 (-0.08%) 02/25/21 Novocure reports Q4 EPS 4c, consensus 12c 01/11/21 Novocure sees FY20 revenue $494.4M, consensus $482.29M 01/11/21 Novocure sees Q4 revenue $144M, consensus $133.26M 10/29/20 Novocure reports Q3 EPS 9c, consensus 3c ZLAB Zai Lab $132.00 / -0.84 (-0.63%) 03/01/21 Zai Lab reports 2020 EPS ($3.46) vs. ($3.03) last year 04/29/21 Novocure - NVCR
Recommendations	Starbucks price target raised to $132 from $116 at Argus » 07:39 04/13/21 04/13 07:39 04/13/21 07:39 SBUX Starbucks $113.81 / +0.64 (+0.57%) Argus analyst John … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SBUX Starbucks $113.81 / +0.64 (+0.57%) 03/30/21 Bakkt launches Bakkt App digital wallet 03/17/21 Starbucks says balance sheet remains strong 03/17/21 Starbucks plans to make its green coffee carbon neutral by 2030 03/17/21 Starbucks CEO says 'encouraging,' but not requiring, employees to get vaccinated SBUX Starbucks $113.81 / +0.64 (+0.57%) 04/12/21 JPMorgan Starbucks price target raised to $104 from $97 at JPMorgan 04/06/21 Fly Intel: Top five analyst initiations 04/06/21 Atlantic Equities Starbucks initiated with an Overweight at Atlantic Equities 03/19/21 Fly Intel: Top five analyst upgrades SBUX Starbucks $113.81 / +0.64 (+0.57%) 01/26/21 Starbucks sees January U.S. SSS down 2% 01/26/21 Starbucks backs FY21 revenue view of $28.0B-$29.0B, consensus $28.5B 01/26/21 Starbucks backs FY21 EPS $2.70-$2.90, consensus $2.81 01/26/21 Starbucks sees Q2 EPS 45c-50c, consensus 59c SBUX Starbucks $113.81 / +0.64 (+0.57%) 04/06/21 Starbucks to discontinue single-use cups in South Korea by 2025, CNBC reports 03/31/21 Starbucks strikes deal with EEOC over alleged racial bias, CNBC reports 03/18/21 Starbucks investors rejects proposal on executive pay, WSJ reports 01/26/21 Walgreens Boots Alliance set to name Starbucks COO Roz Brewer as CEO, WSJ says SBUX Starbucks $113.81 / +0.64 (+0.57%) 04/06/21 Roku, Starbucks initiations among today's top calls on Wall Street 03/19/21 Molson Coors downgrade, Starbucks upgrade among today's top calls on Wall Street 03/16/21 Starbucks upgrade, Ulta downgrade among today's top calls on Wall Street 02/23/21 Starbucks upgrade, Kroger downgrade among today's top calls on Wall Street SBUX Starbucks $113.81 / +0.64 (+0.57%) 03/17/21 Unusually active option classes on open March 17th 02/05/21 Starbucks call volume above normal and directionally bullish 01/26/21 Starbucks options imply 6.1% move in share price post-earnings 12/10/20 Early notable gainers among liquid option names on December 10th
Hot Stocks	Blade Urban Air Mobility to secure up to 20 ALIA Electric Vertical Aircraft » 07:39 04/13/21 04/13 07:39 04/13/21 07:39 EXPC Experience Investment Corp. $10.33 / -0.06 (-0.58%) Blade Urban Air Mobility… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Options EXPC Experience Investment Corp. $10.33 / -0.06 (-0.58%) 12/28/20 Hedgeye adds Experience Investment Corp. to Best Idea Long list, Bloomberg says EXPC Experience Investment Corp. $10.33 / -0.06 (-0.58%) 02/03/21 new option listings on February 3rd
Hot Stocks	Gaming and Leisure Properties to acquire some of Bally's assets for $150M » 07:39 04/13/21 04/13 07:39 04/13/21 07:39 GLPI Gaming and Leisure Properties $43.37 / +0.11 (+0.25%) , BALY Bally's $60.79 / -0.885 (-1.43%) , PENN Penn National $101.84 / -2.33 (-2.24%) Gaming and Leisure… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options GLPI BALY PENN GLPI Gaming and Leisure Properties $43.37 / +0.11 (+0.25%) 07:05 Today Bally's to acquire Tropicana Las Vegas from Gaming and Leisure Properties 01/07/21 Gaming and Leisure Properties promotes Steven Ladany to CDO 01/05/21 Gaming and Leisure Properties appoints Matthew Demchyk to CIO 12/15/20 Penn National to acquire Hollywood Casino Perryville from GLPI for $31.1M BALY Bally's $60.79 / -0.885 (-1.43%) 07:05 Today Bally's to acquire Tropicana Las Vegas from Gaming and Leisure Properties 05:26 Today Bally's to combine with Gamesys Group 04/12/21 Bally's announces agreement with Sinclair Broadcast 03/25/21 Allied Esports Entertainment determines Bally's proposal superior to Element's PENN Penn National $101.84 / -2.33 (-2.24%) 04/07/21 New York state budget for fiscal 2022 legalizes mobile sports betting 04/06/21 Dave Portnoy tweets regarding decline in Penn National shares 03/26/21 PointsBet extends online gaming services framework agreement with Penn National 03/25/21 Nevada reports statewide February gaming win down 26% to $772.41M GLPI BALY PENN GLPI Gaming and Leisure Properties $43.37 / +0.11 (+0.25%) 03/31/21 Mizuho Gaming and Leisure Properties initiated with a Buy at Mizuho 03/15/21 Fly Intel: Top five analyst initiations 03/15/21 KeyBanc Gaming and Leisure Properties initiated with an Overweight at KeyBanc 02/22/21 Deutsche Bank Gaming and Leisure Properties price target raised to $51 from $48 at Deutsche Bank BALY Bally's $60.79 / -0.885 (-1.43%) 04/08/21 KeyBanc Bally's price target raised to $70 from $65 at KeyBanc 03/29/21 Truist Early March casino data looks 'very positive,' says Truist 03/25/21 Stifel Bally's price target raised to $75 from $70 at Stifel 03/24/21 Jefferies Gamesys Group and Bally's an 'interesting combination,' says Jefferies PENN Penn National $101.84 / -2.33 (-2.24%) 04/07/21 Truist Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud' 04/06/21 Credit Suisse Reports, contacts point to sports betting momentum in NY, Credit Suisse says 04/01/21 Credit Suisse NY online sports betting likely to make it into budget, says Credit Suisse 03/29/21 Deutsche Bank New York may be 'kicking the can' on sports betting, says Deutsche GLPI BALY PENN GLPI Gaming and Leisure Properties $43.37 / +0.11 (+0.25%) 02/18/21 Gaming and Leisure Properties reports Q4 FFO 85c, consensus 85c 10/27/20 Gaming and Leisure Propertiesl Partners reports Q3 FFO 89c, consensus 85c BALY Bally's $60.79 / -0.885 (-1.43%) 07:03 Today Bally's sees Q1 revenue $185M, consensus $156.45M 03/04/21 Bally's reports Q4 adjusted EPS 39c, consensus (8c) 11/09/20 Bally's Corporation changes name from Twin River Worldwide Holdings PENN Penn National $101.84 / -2.33 (-2.24%) 02/04/21 Penn National reports Q4 EPS 7c, consensus 24c 02/03/21 Notable companies reporting before tomorrow's open 02/03/21 Notable companies reporting before tomorrow's open 10/29/20 Penn National reports Q3 EPS 93c, consensus 53c 30 Oct 25 Sep 12 May BALY PENN BALY Bally's $60.79 / -0.885 (-1.43%) 03/10/21 Casino companies prepare to compete for NYC-area license, NY Post reports 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says PENN Penn National $101.84 / -2.33 (-2.24%) 04/06/21 New York to approve online sports betting model backed by Cuomo, Action says 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says BALY PENN BALY Bally's $60.79 / -0.885 (-1.43%) 04/09/21 Bet On It: Mobile sports betting added to budget in New York 04/01/21 Bet On It: Sports betting operators make more content-related deals 03/26/21 Bet On It: Las Vegas recovery potentially underway as restrictions loosen 03/24/21 Fly Intel: Wall Street's top stories for Wednesday PENN Penn National $101.84 / -2.33 (-2.24%) 04/09/21 Bet On It: Mobile sports betting added to budget in New York 04/01/21 Bet On It: Sports betting operators make more content-related deals 03/26/21 Bet On It: Las Vegas recovery potentially underway as restrictions loosen 03/19/21 Bet On It: Connecticut governor, two tribes in agreement on sports betting 04/30/21 Gaming and Leisure Properties - GLPI 05/06/21 Penn National - PENN 05/18/21 Bally's Corporation PENN PENN Penn National $101.84 / -2.33 (-2.24%) 03/01/21 Unusually active option classes on open March 1st 01/12/21 Penn National call volume above normal and directionally bullish 12/16/20 Penn National call volume above normal and directionally bullish 12/14/20 Penn National call volume above normal and directionally bullish
Hot Stocks	Partner Communications rejects offers for 20% of company's fiber optic rights » 07:38 04/13/21 04/13 07:38 04/13/21 07:38 PTNR Partner Communications $4.63 / -0.03 (-0.64%) Partner Communications… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research PTNR Partner Communications $4.63 / -0.03 (-0.64%) 01/18/21 Partner says lawsuit against subsidiary recognized as class action 11/18/20 Partner Communications announces consideration of fiber optics transaction PTNR Partner Communications $4.63 / -0.03 (-0.64%) 12/02/20 Barclays Partner Communications price target raised to ILS 1,900 at Barclays

Hot Stocks	BridgeBio announces collaboration agreement with OHSU » 07:38 04/13/21 04/13 07:38 04/13/21 07:38 BBIO BridgeBio $53.97 / -0.51 (-0.94%) BridgeBio Pharma… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals BBIO BridgeBio $53.97 / -0.51 (-0.94%) 07:36 Today BridgeBio announces collaboration agreement with The Lundquist Institute 07:33 Today BridgeBio announces formal collaboration with Brown University 03/31/21 BridgeBio's QED, Helsinn Group collaborate to co-develop infigratinib 03/21/21 BridgeBio announces proof-of-concept data of Encaleret in ADH1 BBIO BridgeBio $53.97 / -0.51 (-0.94%) 03/22/21 Goldman Sachs BridgeBio price target raised to $91 from $83 at Goldman Sachs 03/22/21 Piper Sandler BridgeBio's encaleret likely to be new standard of care, says Piper Sandler 03/04/21 Mizuho BridgeBio price target raised to $86 from $56 at Mizuho 03/01/21 Piper Sandler BridgeBio's first approval small but significant, says Piper Sandler BBIO BridgeBio $53.97 / -0.51 (-0.94%) 02/25/21 BridgeBio reports Q4 EPS ($1.01), consensus (85c) 11/05/20 BridgeBio reports Q3 EPS (98c), consensus (92c) 12 Feb 29 May BBIO BridgeBio $53.97 / -0.51 (-0.94%) 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says
Recommendations	Microsoft price target raised to $300 from $275 at Argus » 07:37 04/13/21 04/13 07:37 04/13/21 07:37 MSFT Microsoft $255.89 / +0.16 (+0.06%) , NUAN Nuance $52.80 / +7.21 (+15.81%) Argus analyst Joseph… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MSFT NUAN MSFT Microsoft $255.89 / +0.16 (+0.06%) 04/12/21 Nuance jumps 23% to $56.00 after Microsoft confirms takeover bid 04/12/21 Microsoft to acquire Nuance for $56.00 per share in cash, or $19.7B 04/12/21 Microsoft to acquire Nuance for $56.00 per share in cash 04/12/21 Unisys names Dwayne Allen as Chief Technology Officer NUAN Nuance $52.80 / +7.21 (+15.81%) 04/12/21 Nuance trading resumes 04/12/21 Nuance to resume trading at 09:00ET 04/12/21 Nuance jumps 23% to $56.00 after Microsoft confirms takeover bid 04/12/21 Microsoft to acquire Nuance for $56.00 per share in cash, or $19.7B MSFT NUAN MSFT Microsoft $255.89 / +0.16 (+0.06%) 06:57 Today BMO Capital BMO Capital positive on Microsoft deal for Nuance 04/12/21 Jefferies Microsoft deal emphasizes healthcare cloud focus, says Jefferies 04/12/21 Stifel Microsoft a 'logical buyer' of Nuance, says Stifel 04/12/21 B. Riley Nuance possible takeout positive for peer LivePerson, says B. Riley NUAN Nuance $52.80 / +7.21 (+15.81%) 06:57 Today BMO Capital BMO Capital positive on Microsoft deal for Nuance 06:22 Today Wedbush Nuance downgraded to Neutral from Outperform at Wedbush 04/12/21 Jefferies Microsoft deal emphasizes healthcare cloud focus, says Jefferies 04/12/21 Stifel Microsoft a 'logical buyer' of Nuance, says Stifel MSFT NUAN MSFT Microsoft $255.89 / +0.16 (+0.06%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/26/21 Microsoft reports Q2 EPS $2.03, consensus $1.64 01/26/21 Notable companies reporting after market close 10/27/20 Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B NUAN Nuance $52.80 / +7.21 (+15.81%) 02/08/21 Nuance raises FY21 revenue view to $1.34B-$1.38B from $1.33B-$1.37B 02/08/21 Nuance sees Q2 EPS 14c-18c, consensus 18c 02/08/21 Nuance reports Q1 adjusted EPS 20c, consensus 18c 11/18/20 Nuance says FY21 guidance reflects continuing Enterprise revenue growth MSFT NUAN MSFT Microsoft $255.89 / +0.16 (+0.06%) 04/11/21 Microsoft in talks to buy Nuance for about $56 per share, Bloomberg says 04/09/21 Hackers scraped data of 500M LinkedIn users, Insider reports 04/06/21 Facebook, Apple and Niantic see a future in augmented -reality glasses, WSJ says 04/01/21 LinkedIn testing Clubhouse competitor, Business Insider reports NUAN Nuance $52.80 / +7.21 (+15.81%) 04/11/21 Microsoft in talks to buy Nuance for about $56 per share, Bloomberg says MSFT NUAN MSFT Microsoft $255.89 / +0.16 (+0.06%) 04/12/21 Fly Intel: Wall Street's top stories for Monday 04/12/21 Fly Intel: Wall Street's top stories at midday 04/12/21 Fly Intel: Pre-market Movers 04/07/21 Game On: An exclusive talk with 'Genesis Noir' developer Feral Cat Den NUAN Nuance $52.80 / +7.21 (+15.81%) 04/12/21 Fly Intel: Wall Street's top stories for Monday 04/12/21 Fly Intel: Wall Street's top stories at midday 04/12/21 Fly Intel: Pre-market Movers 03/08/21 Microsoft, Salesforce rise as analysts get more bullish on software sector 05/24/21 Global Technology, Media & Communications Virtual Conference MSFT NUAN MSFT Microsoft $255.89 / +0.16 (+0.06%) 04/06/21 Microsoft call buyer realizes 130% same-day gains 01/26/21 Microsoft options imply 6.7% move in share price post-earnings 12/17/20 Notable open interest changes for December 17th 11/11/20 Notable open interest changes for November 11th NUAN Nuance $52.80 / +7.21 (+15.81%) 07:35 Today Unusual call flow in option market yesterday 04/07/21 Nuance call volume above normal and directionally bullish 03/23/21 Nuance call buyer realizes 9% same-day gains 02/08/21 Nuance options imply 10.5% move in share price post-earnings
Hot Stocks	BridgeBio announces collaboration agreement with The Lundquist Institute » 07:36 04/13/21 04/13 07:36 04/13/21 07:36 BBIO BridgeBio $53.97 / -0.51 (-0.94%) BridgeBio Pharma and The… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals BBIO BridgeBio $53.97 / -0.51 (-0.94%) 07:33 Today BridgeBio announces formal collaboration with Brown University 03/31/21 BridgeBio's QED, Helsinn Group collaborate to co-develop infigratinib 03/21/21 BridgeBio announces proof-of-concept data of Encaleret in ADH1 02/28/21 BridgeBio, affiliate Origin Biosciences announce FDA approval of NULIBRY BBIO BridgeBio $53.97 / -0.51 (-0.94%) 03/22/21 Goldman Sachs BridgeBio price target raised to $91 from $83 at Goldman Sachs 03/22/21 Piper Sandler BridgeBio's encaleret likely to be new standard of care, says Piper Sandler 03/04/21 Mizuho BridgeBio price target raised to $86 from $56 at Mizuho 03/01/21 Piper Sandler BridgeBio's first approval small but significant, says Piper Sandler BBIO BridgeBio $53.97 / -0.51 (-0.94%) 02/25/21 BridgeBio reports Q4 EPS ($1.01), consensus (85c) 11/05/20 BridgeBio reports Q3 EPS (98c), consensus (92c) 12 Feb 29 May BBIO BridgeBio $53.97 / -0.51 (-0.94%) 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says
Initiation	Cowen starts Instil Bio at Outperform on 'second-mover advantage' » 07:36 04/13/21 04/13 07:36 04/13/21 07:36 TIL Instil Bio $22.13 / +0.05 (+0.23%) , IOVA Iovance Biotherapeutics $29.41 / -0.74 (-2.45%) Cowen analyst Yaron… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly TIL IOVA TIL Instil Bio $22.13 / +0.05 (+0.23%) 04/12/21 Instil Bio presents clinical data for metastatic melanoma at 2021 AACR meeting IOVA Iovance Biotherapeutics $29.41 / -0.74 (-2.45%) 04/09/21 Iovance Biotherapeutics announces clinical data updates for Lifileucel 03/15/21 Iovance Biotherapeutics appoints Igor Bilinsky as COO 12/14/20 Iovance Biotherapeutics appoints Jean-Marc Bellemin as CFO 11/09/20 Iovance Biotherapeutics presents interim data for LN-145 w/ pembrolizumab TIL IOVA TIL Instil Bio $22.13 / +0.05 (+0.23%) 07:07 Today Truist Truist starts Instil Bio with a Buy citing efficacy in solid tumors 06:18 Today Truist Instil Bio initiated with a Buy at Truist 06:00 Today Cowen Instil Bio initiated with an Outperform at Cowen 05:59 Today Morgan Stanley Instil Bio initiated with an Equal Weight at Morgan Stanley IOVA Iovance Biotherapeutics $29.41 / -0.74 (-2.45%) 03/08/21 H.C. Wainwright Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright 01/29/21 Baird Iovance Biotherapeutics assumed at Outperform at Baird 01/14/21 Oppenheimer Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer 12/17/20 Barclays Iovance Biotherapeutics price target raised to $55 from $43 at Barclays IOVA IOVA Iovance Biotherapeutics $29.41 / -0.74 (-2.45%) 02/25/21 Iovance Biotherapeutics reports Q4 EPS (47c), consensus (44c) 19 Mar 29 May TIL TIL Instil Bio $22.13 / +0.05 (+0.23%) 03/20/21 Opening Day: China's Tuya raised $915M in U.S. IPO
Options	Unusual call flow in option market yesterday » 07:35 04/13/21 04/13 07:35 04/13/21 07:35 NUAN Nuance $52.80 / +7.21 (+15.81%) , VVV Valvoline $26.90 / +0.405 (+1.53%) Notable call activity was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NUAN VVV NUAN Nuance $52.80 / +7.21 (+15.81%) 04/12/21 Nuance trading resumes 04/12/21 Nuance to resume trading at 09:00ET 04/12/21 Nuance jumps 23% to $56.00 after Microsoft confirms takeover bid 04/12/21 Microsoft to acquire Nuance for $56.00 per share in cash, or $19.7B VVV Valvoline $26.90 / +0.405 (+1.53%) 12/02/20 Valvoline to acquire 27 quick-lube locations in seven states 11/12/20 Valvoline announces $100M share repurchase 11/12/20 Valvoline raises quarterly dividend to 12.5c per share from 11.25c 11/10/20 Monro announces renewed supply agreement with Valvoline NUAN VVV NUAN Nuance $52.80 / +7.21 (+15.81%) 06:57 Today BMO Capital BMO Capital positive on Microsoft deal for Nuance 06:22 Today Wedbush Nuance downgraded to Neutral from Outperform at Wedbush 04/12/21 Jefferies Microsoft deal emphasizes healthcare cloud focus, says Jefferies 04/12/21 Stifel Microsoft a 'logical buyer' of Nuance, says Stifel VVV Valvoline $26.90 / +0.405 (+1.53%) 03/22/21 Citi Valvoline price target raised to $32 from $28 at Citi 02/08/21 Citi Valvoline price target raised to $28 from $25 at Citi 02/04/21 Monness Crespi Valvoline price target raised to $30 from $26 at Monness Crespi 01/11/21 Seaport Global Valvoline downgraded to Neutral from Buy at Seaport Global NUAN VVV NUAN Nuance $52.80 / +7.21 (+15.81%) 02/08/21 Nuance raises FY21 revenue view to $1.34B-$1.38B from $1.33B-$1.37B 02/08/21 Nuance sees Q2 EPS 14c-18c, consensus 18c 02/08/21 Nuance reports Q1 adjusted EPS 20c, consensus 18c 11/18/20 Nuance says FY21 guidance reflects continuing Enterprise revenue growth VVV Valvoline $26.90 / +0.405 (+1.53%) 02/03/21 Valvoline still sees FY21 adjusted EPS $1.57-$1.67, consensus $1.64 02/03/21 Valvoline reports Q1 adjusted EPS 41c, consensus 36c 10/28/20 Valvoline reports Q4 adjusted EPS 46c, consensus 36c NUAN NUAN Nuance $52.80 / +7.21 (+15.81%) 04/11/21 Microsoft in talks to buy Nuance for about $56 per share, Bloomberg says NUAN NUAN Nuance $52.80 / +7.21 (+15.81%) 04/12/21 Fly Intel: Wall Street's top stories for Monday 04/12/21 Fly Intel: Wall Street's top stories at midday 04/12/21 Fly Intel: Pre-market Movers 03/08/21 Microsoft, Salesforce rise as analysts get more bullish on software sector NUAN VVV NUAN Nuance $52.80 / +7.21 (+15.81%) 04/07/21 Nuance call volume above normal and directionally bullish 03/23/21 Nuance call buyer realizes 9% same-day gains 02/08/21 Nuance options imply 10.5% move in share price post-earnings VVV Valvoline $26.90 / +0.405 (+1.53%) 04/12/21 Call buyer slides into Valvoline position vs 50k share delta hedge

Hot Stocks	Axcella announces AXA1125's IND clearance for the treatment of NASH » 07:34 04/13/21 04/13 07:34 04/13/21 07:34 AXLA Axcella Health $4.24 / -0.09 (-2.08%) Axcella announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events AXLA Axcella Health $4.24 / -0.09 (-2.08%) 03/03/21 Axcella Health names Alison Schecter as President of R&D 01/11/21 Axcella announces IND clearance for AXA1665, program updates AXLA Axcella Health $4.24 / -0.09 (-2.08%) 03/22/21 Wedbush Axcella Health price target lowered to $11 from $19 at Wedbush 03/18/21 Chardan Axcella Health moving forward with two lead programs, says Chardan 11/18/20 Roth Capital Axcella Health initiated with a Buy at Roth Capital 10/27/20 Fly Intel: Top five analyst initiations AXLA Axcella Health $4.24 / -0.09 (-2.08%) 03/17/21 Axcella Health reports Q4 EPS (40c), consensus (36c) 11/12/20 Axcella Health reports Q3 EPS (34c), consensus (41c) 14 May AXLA Axcella Health $4.24 / -0.09 (-2.08%) 11/12/20 Fly Intel: Pre-market Movers 05/20/21 Axcella Health Inc.
Hot Stocks	Aleafia Health introduces wellness brand Noon & Night » 07:34 04/13/21 04/13 07:34 04/13/21 07:34 ALEAF Aleafia Health / + Aleafia Health announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ALEAF Aleafia Health / + 04/07/21 Aleafia Health launches Divvy cannabis brand 03/16/21 Aleafia Health enters Saskatchewan adult-use market 03/02/21 Aleafia Health launches cannabis soft chews by Bogart's Kitchen 02/16/21 Aleafia Health secures licence for Toronto Distribution Centre ALEAF Aleafia Health / + 03/10/21 Cantor Fitzgerald Aleafia Health initiated with a Neutral at Cantor Fitzgerald ALEAF Aleafia Health / + 03/25/21 Aleafia Health reports Q4 revenue C$15.2M vs. C$6.03M last year 11/11/20 Aleafia Health reports Q3 revenue $4.97M vs. $4.96M last year ALEAF Aleafia Health / + 11/12/20 Rising High: Cannabis companies report earnings
Hot Stocks	Geron announces first patient dosed in IMpactMF trial » 07:34 04/13/21 04/13 07:34 04/13/21 07:34 GERN Geron $1.41 / -0.075 (-5.05%) Geron announced that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events GERN Geron $1.41 / -0.075 (-5.05%) 03/11/21 Geron sees FY21 operating expense burn $108M-$112M 12/11/20 Geron opens patient screening, enrollment for IMpactMF trial 12/10/20 Geron achieves 50% enrollment in IMerge Phase 3 clinical trial of imetelstat 10/28/20 Geron discloses safety and efficacy data of IMerge ph2 trial published in JCO GERN Geron $1.41 / -0.075 (-5.05%) 02/18/21 B. Riley Securities Geron transferred with Buy rating at B. Riley Securities 10/14/20 B. Riley Securities Geron shares have 100% potential upside, says B. Riley Securities 08/26/20 H.C. Wainwright Geron price target raised to $7 from $4 at H.C. Wainwright 08/03/20 Fly Intel: Top five analyst initiations GERN Geron $1.41 / -0.075 (-5.05%) 03/11/21 Geron reports Q4 EPS (7c), consensus (6c) 11/05/20 Geron reports Q3 EPS (6c), consensus (6c) 22 May 05/11/21 Geron Corporation
Recommendations	Mattel price target raised to $22 from $19.50 at Stifel » 07:33 04/13/21 04/13 07:33 04/13/21 07:33 MAT Mattel $20.28 / +0.15 (+0.75%) , HAS Hasbro $97.12 / +1.875 (+1.97%) Stifel analyst Drew Crum… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MAT HAS MAT Mattel $20.28 / +0.15 (+0.75%) 03/14/21 Fly Intel: Top five weekend stock stories 02/10/21 Mattel CEO: This was an exceptional quarter 02/09/21 Mattel implementing new 'Optimizing for Growth' program 12/08/20 Mattel names Jonathan Anschell chief legal officer HAS Hasbro $97.12 / +1.875 (+1.97%) 03/25/21 Hasbro's 'Magic: The Gathering Arena' now available on mobile devices 02/25/21 Hasbro sees returning to growth in revenues, earnings, EBITDA in 2021 02/08/21 Hasbro CEO: We are on strong footing to grow in 2021 02/08/21 Hasbro CFO: 2021 is starting with strong year-over-year momentum MAT HAS MAT Mattel $20.28 / +0.15 (+0.75%) 02/25/21 Fly Intel: Top five analyst upgrades 02/25/21 Monness Crespi Mattel upgraded to Buy on favorable risk/reward at Monness Crespi 02/25/21 Monness Crespi Mattel upgraded to Buy from Neutral at Monness Crespi 02/25/21 JPMorgan Mattel price target raised to $27 from $22 at JPMorgan HAS Hasbro $97.12 / +1.875 (+1.97%) 03/29/21 MKM Partners Hasbro reached 'important milestones' in videogame business, says MKM Partners 03/15/21 Truist Hasbro price target raised to $100 from $95 at Truist 02/09/21 DA Davidson Hasbro price target raised to $115 from $105 at DA Davidson 02/09/21 BMO Capital Hasbro price target lowered to $85 from $90 at BMO Capital MAT HAS MAT Mattel $20.28 / +0.15 (+0.75%) 02/09/21 Mattel sees FY21 adjusted EBITDA $775M-$800M vs. $719M last year 02/09/21 Mattel reports Q4 adjusted EPS 40c, consensus 23c 02/09/21 Notable companies reporting after market close 10/22/20 Mattel sees 'strong' adjusted EBITDA growth for FY20 vs. FY19 HAS Hasbro $97.12 / +1.875 (+1.97%) 02/08/21 Hasbro reports Q4 adjusted EPS $1.27, consensus $1.14 10/26/20 Hasbro reports Q3 adjusted EPS $1.88, consensus $1.62 MAT MAT Mattel $20.28 / +0.15 (+0.75%) 03/13/21 Retro stocks suddenly hot, Barron's says 03/05/21 Reddit hires Drew Vollero as CFO ahead of eventual IPO, NY Times reports MAT HAS MAT Mattel $20.28 / +0.15 (+0.75%) 02/16/21 American Express downgrade among today's top calls on Wall Street 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 02/09/21 Fly Intel: After-Hours Movers HAS Hasbro $97.12 / +1.875 (+1.97%) 02/08/21 Fly Intel: Wall Street's top stories for Monday 02/08/21 Fly Intel: Wall Street's top stories at midday 02/08/21 Fly Intel: Pre-market Movers 12/02/20 Verizon upgrade, Salesforce downgrade among today's top calls on Wall Street 05/24/21 Global Technology, Media & Communications Virtual Conference 04/22/21 Mattel - MAT 04/27/21 Hasbro - HAS 05/20/21 Hasbro Inc MAT MAT Mattel $20.28 / +0.15 (+0.75%) 10/23/20 Early notable gainers among liquid option names on October 23rd 10/22/20 Mattel options imply 12.0% move in share price post-earnings 10/21/20 Mattel put volume heavy and directionally bearish
Hot Stocks	BridgeBio announces formal collaboration with Brown University » 07:33 04/13/21 04/13 07:33 04/13/21 07:33 BBIO BridgeBio $53.97 / -0.51 (-0.94%) BridgeBio Pharma and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals BBIO BridgeBio $53.97 / -0.51 (-0.94%) 03/31/21 BridgeBio's QED, Helsinn Group collaborate to co-develop infigratinib 03/21/21 BridgeBio announces proof-of-concept data of Encaleret in ADH1 02/28/21 BridgeBio, affiliate Origin Biosciences announce FDA approval of NULIBRY 02/19/21 BridgeBio, ML Bio Solutions dose first patient in Phase 2 trial of BBP-418 BBIO BridgeBio $53.97 / -0.51 (-0.94%) 03/22/21 Goldman Sachs BridgeBio price target raised to $91 from $83 at Goldman Sachs 03/22/21 Piper Sandler BridgeBio's encaleret likely to be new standard of care, says Piper Sandler 03/04/21 Mizuho BridgeBio price target raised to $86 from $56 at Mizuho 03/01/21 Piper Sandler BridgeBio's first approval small but significant, says Piper Sandler BBIO BridgeBio $53.97 / -0.51 (-0.94%) 02/25/21 BridgeBio reports Q4 EPS ($1.01), consensus (85c) 11/05/20 BridgeBio reports Q3 EPS (98c), consensus (92c) 12 Feb 29 May BBIO BridgeBio $53.97 / -0.51 (-0.94%) 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says

Initiation	GigCapital3 initiated with an Outperform at Northland » 07:33 04/13/21 04/13 07:33 04/13/21 07:33 GIK GigCapital3 $10.05 / -0.085 (-0.84%) Northland initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Events Options GIK GigCapital3 $10.05 / -0.085 (-0.84%) 03/01/21 Lightning eMotors teases use of electric delivery vans by Amazon 01/21/21 Lightning eMotors announces added production capacity 12/11/20 GigCapital3 rises 13.9% GIK GigCapital3 $10.05 / -0.085 (-0.84%) 03/12/21 Benchmark GigCapital3 initiated with a Buy at Benchmark GIK GigCapital3 $10.05 / -0.085 (-0.84%) 03/24/21 DHL Express deploying more electric vans in U.S., Green Car Congress says 11/19/20 Lightning EMotors in talks to go public via GigCapital3, Bloomberg reports 11/19/20 GigCapital3 in talks to bring Lightning eMotors public in merger, Bloomberg says GIK GigCapital3 $10.05 / -0.085 (-0.84%) 03/29/21 Charged: Tesla accepting bitcoin as form of payment for cars 04/21/21 GigCapital3, Inc. GIK GigCapital3 $10.05 / -0.085 (-0.84%) 03/01/21 GigCapital3 call volume above normal and directionally bullish 02/01/21 GigCapital3 call volume above normal and directionally bullish 01/14/21 GigCapital3 call volume above normal and directionally bullish 12/23/20 new option listings and one option delisting on December 23rd
Hot Stocks	Lincoln Electric names Lisa Shapiro as VP, corporate controller » 07:32 04/13/21 04/13 07:32 04/13/21 07:32 LECO Lincoln Electric $122.23 / +0.16 (+0.13%) Lincoln Electric Holdings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events LECO Lincoln Electric $122.23 / +0.16 (+0.13%) 10/27/20 Lincoln Electric sees Q4 organic sales to decline at similiar rate as Q3 10/27/20 Lincoln Electric expects cost reduction actions to generate $80M-$85M in 2020 10/27/20 Lincoln Electric raises quarterly dividend 4.1% to 51c per share 10/20/20 Lincoln Electric raises quarterly dividend to 51c from 49c per share LECO Lincoln Electric $122.23 / +0.16 (+0.13%) 02/16/21 Baird Lincoln Electric early cycle growth seen in 2021, says Baird 01/20/21 Vertical Research Lincoln Electric initiated with a Sell at Vertical Research 12/21/20 Barclays Lincoln Electric price target raised to $130 from $117 at Barclays 10/19/20 Barclays Lincoln Electric upgraded to Overweight on 'best-in-class' profile at Barclays LECO Lincoln Electric $122.23 / +0.16 (+0.13%) 02/12/21 Lincoln Electric reports Q4 adjusted EPS $1.24, consensus $1.06 10/27/20 Lincoln Electric reports Q3 adjusted EPS $1.10, consensus 78c 04/27/21 Lincoln Electric - LECO 04/22/21 Lincoln Electric Holdings Inc
Initiation	Connect Biopharma initiated with an Outperform at SVB Leerink » 07:32 04/13/21 04/13 07:32 04/13/21 07:32 CNTB Connect Biopharma $17.00 / +0.08 (+0.47%) SVB Leerink analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly CNTB Connect Biopharma $17.00 / +0.08 (+0.47%) 04/08/21 Connect Biopharma completes enrollment of CBP-201 Phase 2 trial CNTB Connect Biopharma $17.00 / +0.08 (+0.47%) 04:53 Today Piper Sandler Connect Biopharma initiated with an Overweight at Piper Sandler 19 Mar CNTB Connect Biopharma $17.00 / +0.08 (+0.47%) 03/20/21 Opening Day: China's Tuya raised $915M in U.S. IPO
Hot Stocks	vTv Therapeutics receives breakthrough therapy designation for TTP399 from FDA » 07:31 04/13/21 04/13 07:31 04/13/21 07:31 VTVT vTv Therapeutics $2.58 / -0.17 (-6.18%) vTv Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly Events VTVT vTv Therapeutics $2.58 / -0.17 (-6.18%) 03/23/21 vTv Therapeutics announces patent covering methods of treatment using TTP399 03/18/21 vTv Therapeutics initiates TTP399 mechanistic study 02/23/21 vTv Therapeutics: 800mg of TTP399 showed stat. significant reductions in HbA1c 02/17/21 vTv Therapeutics announces initiation of ascending dose study of HPP737 VTVT vTv Therapeutics $2.58 / -0.17 (-6.18%) 11/05/20 vTv Therapeutics reports Q3 EPS (3c), consensus (9c) VTVT vTv Therapeutics $2.58 / -0.17 (-6.18%) 12/15/20 Fly Intel: After-Hours Movers 05/03/21 vTv Therapeutics Inc.
Recommendations	Square price target raised to $310 from $300 at Needham » 07:31 04/13/21 04/13 07:31 04/13/21 07:31 SQ Square $265.25 / +3.485 (+1.33%) Needham analyst Mayank… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SQ Square $265.25 / +3.485 (+1.33%) 04/06/21 Crypto Council for Innovation launches with Square,Coinbase, Fidelity as members 03/04/21 Square director sells 8.2K shares of common stock 03/04/21 Square to acquire majority stake in Tidal for $297M in cash, stock 03/01/21 Square says Square Financial Services has begun operations SQ Square $265.25 / +3.485 (+1.33%) 04/09/21 Credit Suisse Square price target raised to $290 from $270 at Credit Suisse 04/07/21 Fly Intel: Top five analyst initiations 04/07/21 Oddo BHF Square initiated with a Neutral at Oddo BHF 04/07/21 Barclays Barclays boosts Square target to $330 on potential for international upside SQ Square $265.25 / +3.485 (+1.33%) 02/23/21 Square reports Q4 adjusted EPS 32c, consensus 24c 02/23/21 Notable companies reporting after market close 11/05/20 Square reports Q3 adjusted EPS 34c, consensus 16c 11/05/20 Square reports Q3 revenue $3.03B, consensus $2.07B SQ Square $265.25 / +3.485 (+1.33%) 02/24/21 Square CFO says Cash App saw surge in new bitcoin buyers in January, CNBC says 02/19/21 'Heard on the Street' highlights PayPal, Square among crypto-exposure names 12/24/20 Square held talks to acquire music service Tidal, Bloomberg reports 11/25/20 DOJ wants Intuit to sell Credit Karma tax unit to approve deal, CNBC says SQ Square $265.25 / +3.485 (+1.33%) 04/09/21 The Intersection: Crypto and Wall Street This Week 03/31/21 Apple upgrade, Shopify initiation among today's top calls on Wall Street 03/04/21 Fly Intel: Wall Street's top stories for Thursday 03/04/21 Fly Intel: Wall Street's top stories at midday 05/24/21 Global Technology, Media & Communications Virtual Conference 05/06/21 Square - SQ SQ Square $265.25 / +3.485 (+1.33%) 04/12/21 Square call volume above normal and directionally bullish 04/07/21 Unusually active option classes on open April 7th 03/02/21 Square call volume above normal and directionally bullish 02/23/21 Square options imply 13.4% move in share price post-earnings

Initiation	SunOpta initiated with a Buy at Canaccord » 07:29 04/13/21 04/13 07:29 04/13/21 07:29 STKL SunOpta $15.02 / +0.13 (+0.87%) Canaccord Genuity analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals STKL SunOpta $15.02 / +0.13 (+0.87%) 02/16/21 Cooperman's Omega Advisors buys GM, exits Lee in Q4 02/01/21 SunOpta further invests in plant-based segment, exits frozen fruit plant STKL SunOpta $15.02 / +0.13 (+0.87%) 03/04/21 Craig-Hallum SunOpta price target raised to $25 from $15 at Craig-Hallum 02/03/21 Lake Street SunOpta price target raised to $18 from $15 at Lake Street 12/10/20 Craig-Hallum SunOpta initiated with a Buy at Craig-Hallum 12/09/20 Lake Street SunOpta price target raised to $15 from $9 at Lake Street STKL SunOpta $15.02 / +0.13 (+0.87%) 10/29/20 SunOpta reports Q3 adj. EPS (1c), consensus (5c) 10/29/20 SunOpta reports Q3 EPS (3c), consensus (5c) STKL SunOpta $15.02 / +0.13 (+0.87%) 01/21/21 Hedgeye adds SunOpta to best idea long list, Bloomberg says
Recommendations	JD.com price target lowered to $90 ahead of earnings at Morgan Stanley » 07:28 04/13/21 04/13 07:28 04/13/21 07:28 JD JD.com $78.68 / -1.71 (-2.13%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options JD JD.com $78.68 / -1.71 (-2.13%) 03/22/21 JD.com to invest $800M in ordinary shares of Dada 02/16/21 JD.com to spin-off JD Logistics via separate listing in Hong Kong 12/30/20 JD.com to explore potential spin-off of JD Cloud & AI business to JD Digits 12/29/20 China's Standard for express delivery by unmanned aircraft effective Jan. 1 JD JD.com $78.68 / -1.71 (-2.13%) 03/12/21 HSBC JD.com price target raised to $108 from $103 at HSBC 03/12/21 UBS JD.com price target raised to $110 from $105 at UBS 03/12/21 Citi JD.com price target raised to $120 from $117 at Citi 01/27/21 Macquarie JD.com price target raised to $133 from $107 at Macquarie JD JD.com $78.68 / -1.71 (-2.13%) 03/11/21 JD.com reports Q4 EPS 23c, consensus 19c 03/10/21 Notable companies reporting before tomorrow's open 03/10/21 Notable companies reporting before tomorrow's open 11/16/20 JD.com reports Q3 EPS 50c, consensus 40c JD JD.com $78.68 / -1.71 (-2.13%) 03/11/21 Chinese regulators considering fine over $975M against Alibaba, WSJ says 02/21/21 Alibaba, Pinduoduo join fight against looming China food crisis, Bloomberg says 12/30/20 China fines Alibaba, JD.com, Vipshop for mispricing products, WSJ reports 12/12/20 Delisting Chinese companies bad for investors, right thing to do, Barron's says JD JD.com $78.68 / -1.71 (-2.13%) 03/11/21 Fly Intel: Pre-market Movers 01/26/21 Comcast upgrade, Bed Bath & Beyond downgrade among top calls on Wall Street 01/25/21 Walmart downgrade, Alibaba initiation among today's top calls on Wall Street 01/05/21 Tesla downgrade, McDonald's initiation among today's top calls on Wall Street JD JD.com $78.68 / -1.71 (-2.13%) 03/11/21 Unusually active option classes on open March 11th 01/05/21 JD.com call volume above normal and directionally bullish 01/05/21 Unusually active option classes on open January 5th 12/30/20 Unusually active option classes on open December 30th
Downgrade	Aphria downgraded to Hold on industry headwinds at Canaccord » 07:28 04/13/21 04/13 07:28 04/13/21 07:28 APHA Aphria $13.93 / -2.34 (-14.38%) , TLRY Tilray $17.15 / -2.62 (-13.25%) Canaccord analyst Matt… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options APHA TLRY APHA Aphria $13.93 / -2.34 (-14.38%) 04/12/21 Uber CEO tells CNBC it may get into cannabis delivery 04/05/21 Aphria: ISS, Glass Lewis recommend shareholders vote 'FOR' Tilray merger 04/05/21 ISS, Glass Lewis recommend Tilray holders vote fo Aphria transaction 03/31/21 NY Governor Cuomo signs bill to legalize adult-use cannabis TLRY Tilray $17.15 / -2.62 (-13.25%) 04/12/21 Uber CEO tells CNBC it may get into cannabis delivery 04/05/21 Aphria: ISS, Glass Lewis recommend shareholders vote 'FOR' Tilray merger 04/05/21 ISS, Glass Lewis recommend Tilray holders vote fo Aphria transaction 03/31/21 NY Governor Cuomo signs bill to legalize adult-use cannabis APHA TLRY APHA Aphria $13.93 / -2.34 (-14.38%) 06:31 Today Canaccord Aphria downgraded to Hold from Speculative Buy at Canaccord 04/12/21 Alliance Global Partners Alliance Global trims Aphria price target to C$24, says long-term view intact 04/08/21 Alliance Global Partners Aphria price target raised to $26 from $20 at Alliance Global Partners 04/06/21 Stifel Aphria price target raised to C$22 from C$15.50 at Stifel TLRY Tilray $17.15 / -2.62 (-13.25%) 04/06/21 Stifel Aphria price target raised to C$22 from C$15.50 at Stifel 03/29/21 Stifel Stifel says New York adult use cannabis market represents $5B opportunity 02/18/21 Fly Intel: Top five analyst downgrades 02/18/21 Roth Capital Tilray price target raised to $25 from $10 at Roth Capital APHA TLRY APHA Aphria $13.93 / -2.34 (-14.38%) 04/12/21 Aphria reports Q3 adjusted EPS (C$0.15) vs. (C$0.04) a year ago 01/14/21 Aphria reports Q2 adjusted EPS C$0.01 vs. (C$0.19) a year ago 10/15/20 Aphria reports Q1 EPS (C$0.02) vs. C$0.07 year ago TLRY Tilray $17.15 / -2.62 (-13.25%) 02/17/21 Tilray reports Q4 EPS (2c), consensus (15c) 11/09/20 Tilray sees positive or break even adjusted EBITDA in Q4 11/09/20 Tilray reports Q3 EPS (2c), consensus (21c) APHA TLRY APHA Aphria $13.93 / -2.34 (-14.38%) 03/24/21 Deal reached on bill legalizing marijuana in NY, Spectrum News NY1 says 03/17/21 Marijuana banking bill to be reintroduced, Marijuana Moment's Angell says 03/15/21 NY Governor Cuomo says state 'very close' to legalizing marijuana, RF says 03/11/21 Peoples-Stokes sees marijuana legalization deal soon, Buffalo News reports TLRY Tilray $17.15 / -2.62 (-13.25%) 03/24/21 Deal reached on bill legalizing marijuana in NY, Spectrum News NY1 says 03/17/21 Marijuana banking bill to be reintroduced, Marijuana Moment's Angell says 03/15/21 NY Governor Cuomo says state 'very close' to legalizing marijuana, RF says 03/11/21 Peoples-Stokes sees marijuana legalization deal soon, Buffalo News reports APHA TLRY APHA Aphria $13.93 / -2.34 (-14.38%) 04/12/21 Fly Intel: Wall Street's top stories for Monday 04/12/21 Fly Intel: Wall Street's top stories at midday 04/12/21 Fly Intel: Pre-market Movers 04/08/21 Rising High: Canopy Growth to acquire The Supreme Cannabis Company in $435M deal TLRY Tilray $17.15 / -2.62 (-13.25%) 04/08/21 Rising High: Canopy Growth to acquire The Supreme Cannabis Company in $435M deal 04/01/21 Rising High: An exclusive talk with cannabinoid market research firm BDSA 03/25/21 Rising High: An exclusive talk with medical cannabis digital network SheCann 03/18/21 Rising High: An exclusive talk with cannabis retailer Fire & Flower APHA TLRY APHA Aphria $13.93 / -2.34 (-14.38%) 03/15/21 Aphria call volume above normal and directionally bullish 02/12/21 Aphria call volume above normal and directionally bullish 02/09/21 Aphria call volume above normal and directionally bullish 01/13/21 Aphria call volume above normal and directionally bullish TLRY Tilray $17.15 / -2.62 (-13.25%) 03/31/21 Tilray call volume above normal and directionally bullish 02/17/21 Tilray options imply 24.1% move in share price post-earnings 02/16/21 Largest borrow rate increases among liquid names 02/12/21 Notable open interest changes for February 12th
Downgrade	Cadence Bancorp downgraded to Hold from Buy at Truist » 07:28 04/13/21 04/13 07:28 04/13/21 07:28 CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) , BXS BancorpSouth $30.45 / -1.79 (-5.55%) Truist analyst Jennifer… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CADE BXS CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) 04/12/21 Cadence Bancorp rises 7.1% 04/12/21 BancorpSouth, Cadence Bancorp announce all-stock merger agreement 01/25/21 Cadence Bancorp reports book value per share $15.83 as of December 31 01/25/21 Cadence Bancorp raises dividend to 15c BXS BancorpSouth $30.45 / -1.79 (-5.55%) 04/12/21 BancorpSouth, Cadence Bancorp announce all-stock merger agreement 04/07/21 BancorpSouth gets FDIC approval of mergers with National United, FNS Bancshares 01/13/21 BancorpSouth Bank to acquire FNS Bancshares for $90.04 per share 12/09/20 BancorpSouth announces new 6M share repurchase authorization CADE BXS CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) 06:37 Today Raymond James Cadence Bancorp downgraded to Market Perform from Outperform at Raymond James 06:10 Today RBC Capital Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital 04/12/21 RBC Capital Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital 02/23/21 Stephens Stephens raises Regions price target to $23, sees possible deal for Cadence BXS BancorpSouth $30.45 / -1.79 (-5.55%) 06:10 Today RBC Capital Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital 12/03/20 Stephens National United deal shouldn't preclude more M&A at BancorpSouth, says Stephens 11/16/20 DA Davidson BancorpSouth downgraded to Neutral from Buy at DA Davidson 11/16/20 DA Davidson BancorpSouth downgraded to Neutral from Buy at DA Davidson CADE BXS CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) 01/25/21 Cadence Bancorp reports Q4 adjusted EPS $1.57, consensus $1.48 10/21/20 Cadence Bancorp reports Q3 EPS 40c, consensus 19c BXS BancorpSouth $30.45 / -1.79 (-5.55%) 01/25/21 BancorpSouth reports Q4 operating EPS ex MSR 69c, consensus 62c 10/21/20 BancorpSouth reports Q3 EPS 69c, consensus 53c CADE CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) 01/07/21 Fly Intel: After-Hours Movers 04/22/21 Cadence Bancorp - CADE 04/22/21 BancorpSouth - BXS 05/06/21 Cadence Bancorporation
General news	European stock markets are mostly higher, » 07:25 04/13/21 04/13 07:25 04/13/21 07:25 $ECON Economic Data / + European stock markets… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><<

Events

Earnings calls, analyst events, roadshows and more

EARS
Today at 08:00

Auris Medical - EARS Conference Calls
BFRA
Today at 08:00

Biofrontera - BFRA Conference Calls
OGI
Today at 08:00

Organigram - OGI Conference Calls
Today at 08:30

CPI Ex Food & Energy Y/Y: March 2021 Government Event
Today at 08:30

Consumer Price Index M/M: March 2021 Government Event
Today at 08:30

Consumer Price Index Y/Y: March 2021 Government Event
Today at 08:30

CPI Ex-Food & Energy M/M: March 2021 Government Event
MGA
Today at 08:30

Magna International, Inc. CL A Firm Sponsored Meetings
KKR
Today at 08:30

KKR & Co. Inc. Firm Sponsored Meetings
Today at 08:55

Redbook Store Sales Y/Y: 4/10/21 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank $35.10 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares
Fri	No deals

View All Syndicate Announcements »

Fluor provides update on review of two projects

TODAY'S FREE FLY STORIES

Get Full Fly Access